| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.8 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |